Zynex says NeuroMove Stroke Recovery System proves beneficial to stroke patients

By Lisa Kerner

Erie, Pa., March 1 - Zynex Medical Holdings, Inc. said stroke victims who took part in an independent clinical study conducted at the University of Cincinnati College of Medicine were able to participate in a specialized physical therapy program after being treated with the company's NeuroMove Stroke Recovery System.

The results of the study were published in the January edition of the Archives of Physical Medicine and Rehabilitation, according to a company news release.

"The study found that after using the NeuroMove for a short period of time, patients who were unable to use their wrist or fingers at all regained enough movement to progress to the next level of therapy," Zynex president and chief executive officer Thomas Sandgaard said in the release.

"The NeuroMove System provided the patients the ability to undergo Modified Constraint Induced Therapy (mCIMT), a form of physical therapy, where they continued to make progress in their recovery."

The NeuroMove System teaches the healthy parts of the brain to compensate for damaged areas using electrical stimulation. It monitors muscle activity and selects signals from the brain indicating that the patient is attempting to move a certain muscle. Often the connection between the brain and muscle can eventually be reestablished, the company said.

Zynex, based in Littleton, Colo., provides therapeutic devices for patients with functional disability.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.